{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:26:24Z","timestamp":1793996784545,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.esmoop.2021.100363","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T17:51:06Z","timestamp":1641837066000},"page":"100363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular diseases among diffuse large B-cell lymphoma long-term survivors in Asia: a multistate model study"],"prefix":"10.1016","volume":"7","author":[{"given":"S.F.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Vellayappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.Y.-F.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.C.-K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Luque-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.esmoop.2021.100363_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.2010.32.8427","article-title":"Long-term complications of lymphoma and its treatment","volume":"29","author":"Ng","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2021.100363_bib2","doi-asserted-by":"crossref","first-page":"e008350","DOI":"10.1136\/bmjopen-2015-008350","article-title":"Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy","volume":"5","author":"Hung","year":"2015","journal-title":"BMJ Open"},{"issue":"25","key":"10.1016\/j.esmoop.2021.100363_bib3","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100363_bib4","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.esmoop.2021.100363_bib5","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","article-title":"Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma","volume":"107","author":"Moser","year":"2006","journal-title":"Blood"},{"issue":"34","key":"10.1016\/j.esmoop.2021.100363_bib6","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1200\/JCO.2017.72.4211","article-title":"Preexisting cardiovascular risk and subsequent heart failure among non-Hodgkin lymphoma survivors","volume":"35","author":"Salz","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2021.100363_bib7","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2004.06.033","article-title":"Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults","volume":"22","author":"Hequet","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.esmoop.2021.100363_bib8","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1002\/cncr.24391","article-title":"Health status and quality of life among non-Hodgkin lymphoma survivors","volume":"115","author":"Smith","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100363_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/cncr.27781","article-title":"Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma","volume":"119","author":"Jensen","year":"2013","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100363_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2011.40.6249","article-title":"Quality of life among long-term survivors of non-Hodgkin lymphoma: a follow-up study","volume":"31","author":"Smith","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100363_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3109\/10428194.2014.921914","article-title":"The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphoma","volume":"56","author":"Tsai","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.esmoop.2021.100363_bib12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.esmoop.2021.100363_bib13","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/cncr.31695","article-title":"Congestive heart failure in older adults diagnosed with follicular lymphoma: a population-based study","volume":"124","author":"Kenzik","year":"2018","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.esmoop.2021.100363_bib14","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1200\/JCO.2007.14.1242","article-title":"Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin\u2019s lymphoma","volume":"26","author":"Hershman","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100363_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3816\/CLM.2005.n.038","article-title":"Late non-neoplastic events in patients with aggressive non-Hodgkin\u2019s lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials","volume":"6","author":"Moser","year":"2005","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.esmoop.2021.100363_bib16","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"Br Med J"},{"issue":"13","key":"10.1016\/j.esmoop.2021.100363_bib17","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.100.13.1481","article-title":"Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.esmoop.2021.100363_bib18","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/eurheartj\/ehy913","article-title":"Depression and coronary heart disease: 2018 position paper of the ESC Working Group on coronary pathophysiology and microcirculation","volume":"41","author":"Vaccarino","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.esmoop.2021.100363_bib19","author":"Leung"},{"issue":"29","key":"10.1016\/j.esmoop.2021.100363_bib20","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1002\/sim.7448","article-title":"Parametric multistate survival models: flexible modelling allowing transition-specific distributions with application to estimating clinically useful measures of effect differences","volume":"36","author":"Crowther","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.esmoop.2021.100363_bib21","series-title":"Stata Statistical Software: Release 16","year":"2019"},{"key":"10.1016\/j.esmoop.2021.100363_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/1536867X20976311","article-title":"merli\u017d: a unified modeling framework for data analysis and methods development in Stata","volume":"20","author":"Crowther","year":"2018","journal-title":"Stata J"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100363_bib23","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1200\/JCO.1997.15.8.2945","article-title":"Elderly patients with aggressive non-Hodgkin\u2019s lymphoma: disease presentation, response to treatment, and survival--a Groupe d\u2019Etude des Lymphomes de l\u2019Adulte study on 453 patients older than 69 years","volume":"15","author":"Bastion","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2021.100363_bib24","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/cncr.29290","article-title":"Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma","volume":"121","author":"Williams","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100363_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjh.12765","article-title":"Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study","volume":"165","author":"Wieringa","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100363_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/10428194.2013.788176","article-title":"Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi","volume":"55","author":"Merli","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.esmoop.2021.100363_bib27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1634\/theoncologist.2014-0113","article-title":"Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis","volume":"19","author":"Hamlin","year":"2014","journal-title":"Oncologist"},{"issue":"20","key":"10.1016\/j.esmoop.2021.100363_bib28","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/blood-2017-05-736975","article-title":"Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma","volume":"130","author":"Lin","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100363_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/joim.12849","article-title":"Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study","volume":"285","author":"W\u00e4sterlid","year":"2019","journal-title":"J\u00a0Intern Med"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100363_bib30","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/cncr.28549","article-title":"Insurance status is related to diffuse large B-cell lymphoma survival","volume":"120","author":"Han","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100363_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdq609","article-title":"Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper","volume":"22","author":"Aapro","year":"2011","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100363_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2021.100363_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.15603","article-title":"Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines","volume":"183","author":"Baech","year":"2018","journal-title":"Br J Haematol"},{"issue":"14","key":"10.1016\/j.esmoop.2021.100363_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.esmoop.2021.100363_bib35","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1182\/bloodadvances.2020002737","article-title":"Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong","volume":"4","author":"Lee","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.esmoop.2021.100363_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1472-6963-8-138","article-title":"Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004\u20132007 as an example of the potential and pitfalls of using routinely collected electronic patient data","volume":"8","author":"Wong","year":"2008","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.esmoop.2021.100363_bib38","doi-asserted-by":"crossref","first-page":"h6926","DOI":"10.1136\/bmj.h6926","article-title":"Cardiovascular outcomes associated with use of clarithromycin: population based study","volume":"352","author":"Wong","year":"2016","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100363_bib39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.esmoop.2021.100363_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.esmoop.2021.100363_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2018.05.006","article-title":"Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: a Danish population-based cohort study","volume":"99","author":"Juul","year":"2018","journal-title":"Eur J Cancer"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921003252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921003252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:25:04Z","timestamp":1761855904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702921003252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2059702921003252"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100363","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular diseases among diffuse large B-cell lymphoma long-term survivors in Asia: a multistate model study","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100363"}}